Notably, in a parallel microdystrophin study sponsored by Genethon, investigators observed up to 85% of dystrophin positive myofibres by immunofluorescence 8-weeks post injection (First clinical trial results of gene therapy (GNT0004) for Duchenne muscular dystrophy presented at international myology (2024) Congress Available from: https://www.genethon.com/first-clinical-trial-results-of-gene-therapy-gnt0004-for-duchenne-muscular-dystrophy-presented-at-international-myology-2024-congress/). Here, DMD is linked to Duchenne muscular dystrophy.